In conclusion, this study utilizes several cohorts to identify the generally overexpressed HNRNPs, HNRNPL, in PC and demonstrates that downregulation of HNRNPL inhibits pancreatic cancer progression. This evidence concerns the gene HNRNPL and familial pancreatic carcinoma.